Brad Hirsch, MD:

Brad is co-founder of Highlander Health, a firm advancing evidence generation and personalized health care for the new era of medical innovation. Brad is an oncologist, entrepreneur, and product leader dedicated to driving transformation at the intersection of research and care. Highlander Health has two parts. Highlander Health Institute is an all-stakeholder platform that creates transparent answers to how best to assure safe, effective, and accessible treatments. Highlander Health Partners invests in companies and technology crucial to personalized care for all.

Prior to Highlander Health, Brad served as Head of Product at Verily, Alphabet's life sciences company where he led the development and delivery of solutions to accelerate clinical research and improve care. He joined Verily through its acquisition of SignalPath, a clinical trials technology solution, where he was Co-Founder, CEO, and Chair.

Previously, Brad held roles at Flatiron Health, Texas Oncology, and served on the faculty of Duke University. In addition to his corporate and academic roles, Brad gives back through a number of philanthropic commitments, including Board roles at the Fuqua School of Business at Duke University, St. Mark's School of Texas, and AT&T Performing Arts of Dallas.

Brad has a long history with NOLS, starting in 2001 when he participated in a semester in Alaska. Since that time, he has visited branches around the world during his wilderness travels. The organization has had a dramatic impact on his life, inspiring him to give back in any way possible. Brad is based in Dallas with his wife and two children.